Introduction {#sec1_1}
============

Over the last decades obesity has taken on epidemic proportions \[[@B1]\]. Obesity increases all-cause mortality and is an independent risk factor for type-2 diabetes, cardiovascular disease (CVD) and hypertension, making it one of the major public health problems in developing countries \[[@B1],[@B2]\]. Severe obesity, defined as a BMI ≥ 40 kg/m^2^, is associated with a significantly higher prevalence of comorbidities \[[@B2]\] and rates of premature mortality twice as those seen in less severe degrees of obesity \[[@B3]\]. The associated socio-economic costs are extremely high and likely to increase \[[@B4]\].

Life-style interventions involving diet, exercise and behaviour modification are still the cornerstone in obesity treatment. Although conservative treatments of obesity can result in short-term weight loss of approximately 10% body weight, this is usually not sustained in the long term \[[@B5]\]. This has led some to consider bariatric surgery as the only sustainable treatment for morbid obesity \[[@B6]\]. However, not all patients with morbid obesity want bariatric surgery \[[@B7]\], those who want are not always eligible, and less than 1% of those are treated annually \[[@B8]\]. Moreover, it is important to highlight that even small weight losses (between 5 and 10% of initial body weight) can have large health benefits if sustained in the long term \[[@B9]\]. A weight loss of only 3-4 kg sustained for 3-4 years has been shown to reduce the development of type 2 diabetes up to 58% in obese individuals \[[@B10]\]. Therefore, non-surgical alternatives for severe obesity, which facilitate long-term weight loss maintenance, need to be developed.

The concept of weight loss camps or residential programmes for severely obese adult patients is relatively new, and few data is available, particularly in the long term. Short-term results are usually good, with an average 7% weight loss being reported after 3-4 weeks \[[@B11],[@B12]\] and 15% after 21 weeks \[[@B13]\] of participation in residential weight loss programmes consisting of diet, physical activity and behavioural modification in patients with severe obesity. These changes have been shown to be maintained at 1 year \[[@B12]\], to be of small clinical significance at follow-ups between 2 and 4 years \[[@B13]\] and to disappear almost completely at 5 years \[[@B14]\]. However, all previous studies consisted of only one unique stay at a residential facility and did not involve any additional contact between patients and 'health providers' in order to reinforce the life-style modifications and keep the patients motivated to long-term changes.

We have recently shown that residential intermittent programmes for weight loss involving several stays over time lead to clinical significant weight loss and improvements in risk factors and comorbidities resolution at 1 year similar to those observed after bariatric surgery, despite a much lower weight reduction (40 ± 14 vs. 22 ± 13 kg) \[[@B15]\].

The present study aims to determine if length of the first stay impacts on weight loss and cardiovascular fitness at 1 and 2 years in severely obese patients enrolled in an intermittent residential programme.

Material and Methods {#sec1_2}
====================

Participants {#sec2_1}
------------

179 participants (117 women and 62 men) were included in this analysis. The inclusion criteria were an age between 18 and 60 years and a BMI \> 40 kg/m^2^ (or BMI \> 35 kg/m^2^ with comorbidities). The exclusion criteria included pregnancy, enrolment in another obesity treatment, previous bariatric surgery, drug or alcohol abuse and physical or mental impairment that interfere with the ability to comply to treatment. This study was conducted according to the guidelines laid down in the Declaration of Helsinki and was approved by the regional Ethics Committee (Central Norway, Trondheim, Norway). Written informed consent was obtained from all participants before enrolling in the study.

Study Protocol {#sec2_2}
--------------

Patients with severe obesity referred to the Centre for Obesity at St. Olavs Hospital, Trondheim, Norway, were offered the choice to attend a residential weight loss programme at Røros Rehabilitation Centre (RRC) (Norway). This intervention consists of a 'continuous care' weight loss programme with intermittent stays at the RRC. The groups from January 2005 to February 2007 had five stays at the RRC over a 2-year period as follows (programme A): a long initial stay of 8 weeks at RRC, 8 weeks at home, 4 weeks at RRC, 4-5 months at home, 2 weeks at RRC, 6 months at home, 2 weeks at RRC, 6 months at home and 2 weeks at RRC. Because of work and family commitments many participants complained of the duration of the first stay. For that reason, a new programme (programme B) was introduced from February 2007 onwards involving a shorter first stay at RRC: 2 instead of 8 weeks.

During the first visit at RRC, each patient had an individual consultation with a team of health professionals (dietician, physical activity (PA) therapist, psychologist and psychiatric nurse). Patients took part in structured PA supervised by a PA therapist (2 sessions of group PA + 1 individual/day) and in a nutrition education programme on how to estimate energy needs, energy intake from food, healthy eating, healthy cooking etc. Participants had 6 meals/day (4 main meals: breakfast, lunch, dinner and evening meal and 2 snacks). Some of the meals were provided by the kitchen, others were prepared by the participants in groups, with the help of the dietician and a chef. All food/meals provided were ad libitum and followed the following guidelines: i) Eat at least five servings of vegetables, fruits and berries every day; ii) eat whole-grain products every day; iii) choose low-fat dairy products as part of the daily diet; iv) eat fish for dinner 2 or 3 times a week; v) choose lean meats and low-fat meat products; vi) limit the amount of processed meat and red meat; vii) select edible oils, liquid margarine and soft margarine rather than hard margarine and butter; viii) choose foods low in salt and limit the consumption of salt in cooking and food; ix) avoid foods and drinks high in sugar (choose water instead). The same guidelines were used during the nutritional education programme, and participants were asked to follow them during the home stays. The cornerstone of both programmes consisted on dynamic group-based psychotherapy where each patient was in charge of their own treatment. Moreover, a great effort was put into translating new knowledge and practices acquired at RRC to the home environment and establishing long-term support at home.

Body weight was assessed at baseline and before and after each visit, and VO~2~ peak was measured at baseline and at the beginning of each visit at RRC. Before measurements of VO~2~ peak, participants were informed about the test and instructed to exercise to their maximum limit. To familiarise with treadmill walking, the test started on a flat treadmill where participants learned to walk without grasping the handrails. After a warm-up period, a facemask was placed on the subject\'s face for metabolic measurements using Oxycon Delta (Jaeger, Hochberg, Germany). The VO~2~ peak test was performed using a ramp protocol where the speed was constant and the incline was increased with 2% every minute until VO~2~ peak was reached. The average of the three highest 10-s measurements determined VO~2~ peak. Heart rate was continuously recorded using a Polar Sport Tester (Polar Electro OY, Kempele, Finland).

A flow diagram of the study can be seen in figure [1](#F1){ref-type="fig"}.

Statistical Analyses {#sec2_3}
--------------------

Statistical analysis was carried out using SPSS 15.0 (SPSS Inc., Chicago, IL, USA). All variables were checked regarding their normal distribution using the Shapiro-Wilk test. Statistical significance was assumed at p \< 0.05, unless otherwise stated.

Differences in baseline characteristics between the two groups were assessed using independent sample t-tests for continuous variables (BMI, weight, VO~2~ peak and age) and χ^2^ for categorical variables (male/female ratio). The same approach was used to look at differences between those who completed and those who withdrew from the study.

Because baseline weight was significantly higher in group A compared with group B and it was significantly correlated with weight loss at 1 year (r = 0.182, p \> 0.05, n = 162) (but not at 2 years), we performed regression analysis to look at differences in weight between groups at different time points, using baseline weight as a covariate. Although baseline VO~2~ peak (ml/kg/min) was significantly lower in programme A compared with B, there was no correlation with weight loss at either 1 or 2 years, and, for that reason, this variable was not included in the model. Changes in weight over time in each group were assessed by repeated measures ANOVA, using the Bonferroni test to adjust for multiple comparisons.

Changes in VO~2~ peak (ml/kg/min) over time between programmes were assessed by a between/within subjects ANOVA, with group as between subjects variable and time as the within subjects variable. Differences in VO~2~ peak (ml/kg/min) changes at 1 and 2 years in both groups were assessed by independent samples t-tests.

Apart from analysis of completers, we also performed two intention-to-treat analyses: 'last observation carried forward' and 'baseline values carried forward'.

Results {#sec1_3}
=======

Participants {#sec2_4}
------------

The study sample had a mean age of 42 ± 11 years and a BMI of 44.0 ± 5.5 kg/m^2^. Table [1](#T1){ref-type="table"} summarizes the baseline characteristics of the participants by treatment group. Age, VO~2~ peak (ml/min) and male/female ratio did not differ between groups, but baseline weight and BMI were significantly higher and VO~2~ peak (ml/kg/min) significantly lower in group A compared with group B.

Weight Loss at 1 and 2 Years {#sec2_5}
----------------------------

There were no significant differences in baseline BMI, weight, VO~2~ peak (expressed in ml/min or ml/kg/min) or age between those who completed the study and those who withdrew at 1 year. However, more men than women withdrew at 1 year (17.7 vs. 5.1%; p \< 0.05). There were also no significant differences in baseline BMI, weight, VO~2~ peak (expressed in ml/min or ml/kg/min) or gender ratio between those who completed the study and those who withdrew at 2 years, but completers were older compared with those who withdrew (43 ± 10 vs. 39 ± 11 years; p \< 0.05).

Analysis of completers showed that participants in programme A lost significantly more weight, both at 1 and 2 years, compared with those in programme B (20.7 ± 10.8 vs. 13.5 ± 8.1 kg and 16.0 ± 12.7 vs. 7.9 ± 11.2 kg respectively). A similar pattern was observed with intention-to-treat analysis (table [2](#T2){ref-type="table"}).

The percentage of participants who lost at least 5 or 10% of their initial body weight at 2 years within each treatment programme can be seen in table [3](#T3){ref-type="table"}. Significantly more patients in programme A were able to achieve 5% and 10% weight loss at 2 years, compared with programme B (81 vs. 55% (p \< 0.01) and 63 vs. 25% (p \< 0.0001) respectively).

Changes in Weight throughout the 2-Year Intervention Period {#sec2_6}
-----------------------------------------------------------

Changes in weight throughout the 2-year intervention period in patients who underwent programme A and B can be seen in figure [2](#F2){ref-type="fig"}. There was a significant effect of time on body weight in both treatment groups (p \< 0.0001 for both).

Participants lost significant amounts of weight at every stay at the RRC with both programmes, however, weight loss with programme A was significantly larger than with programme B both at the first (V1) and fourth (V4) visits: −12.5 ± 4.3 kg versus −3.2 ± 1.8 kg (p \< 0.0001) and −1.8 ± 1.4 kg versus −0.7 ± 1.4 kg (p \< 0.0001) respectively. Participants in both programmes also lost significant and similar amounts of weight in the first home stay (H1: −3.9 ± 7.4 kg vs. −5.0 ± 4.1 kg, p \> 0.05), were able to maintain their weight during the second home stay (H2) and regained weight on both the third and fourth home stays (H3: 5.2 ± 5.4 kg vs. 2.6 ± 4.0 kg (p \< 0.01) and H4: 5.1 ± 4.2 kg vs. 5.7 ± 8.6 kg (p \> 0.05)).

Changes in Cardiovascular Fitness Overtime and at 1 and 2 Years {#sec2_7}
---------------------------------------------------------------

Changes in VO~2~ peak (ml/kg/min) over time in both programmes can be seen in figure [3](#F3){ref-type="fig"}. ANOVA revealed a significant effect of time (p \< 0.0001) and a time × group interaction (p \< 0.0001), but no main effect of group. There was a significant difference in VO~2~ peak (ml/kg/min) between groups at baseline, but no difference at any other time point.

There was a larger improvement in VO~2~ peak (ml/kg/min) at both 1 and 2 years with programme A compared with programme B (7.8 vs. 3.6 ml/kg/min (p \< 0.0001) and 5.6 vs. 2.5 ml/kg/min (p \< 0.01) respectively).

Discussion {#sec1_4}
==========

The main objective of this study was to compare weight loss and weight loss maintenance at 1 and 2 years and improvements in cardiovascular fitness over the same period in patients with severe obesity after two intermittent residential programmes differing in the length of their first stay. Programme A, with a first stay at RRC of 8 weeks, led to an initial weight loss that was, on average, four times higher than that observed with programme B, with a first stay of 2 weeks. So, the magnitude of weight loss was in fact directly proportional to the length of the stay. After that, participants of both programmes behaved in a very similar way, which is expected since the programmes were identical with the exception of the length of the first stay. Participants lost weight in their first home stay and second visit at the RRC, maintained their weight in the second home visit and lost weight during the third stay at RRC. After that, which corresponded to approximately 1 year, participants started to regain weight during their home stays and to loose minimal amounts of weight during their stays at the RRC. These findings may suggest that after the first year home stays need to be shortened and more frequent stays at the RRC are necessary in order to minimise weight regain. The better initial outcome of programme A was also maintained at both 1 and 2 years; those following programme A lost on average 34% more weight at 1 year and 51% more weight at 2 years compared with those following programme B.

A larger initial weight loss has been consistently shown to be a good predictor of weight loss maintenance in the long term (2-3 years) \[[@B16],[@B17],[@B18]\]. This is in line with our findings showing that a larger initial weight loss achieved through a longer stay at a residential programme for morbid obesity is associated with better weight loss at 1 year and better weight loss maintenance at 2 years. Previous studies have shown that weight loss camps or in-patient programmes consisting of diet, physical activity and behavioural modification lead to very good short-term results with an average weight loss between 7 and 15% for periods between 3 and 21 weeks \[[@B11],[@B12],[@B13]\], which is consistent with our results. The problem is that, as soon as these programmes end and the patients are left without follow-up and support, weight regain starts to occur. Christiansan and colleagues \[[@B13]\] showed that, even though morbid obese patients can lose around 15% of their body weight during a 21-week stay at a weight loss camp, participants regain more than half of the initial weight loss between 2 and 4 years. Similar results have been shown with behavioural or psychodynamic in-patient treatment: an average 5% weight loss can be observed after 7 weeks of in-patient treatment, but by 3 years, more than half of the weight had been regained \[[@B17]\]. By using intermittent residential programmes where patients receive continuing support, although weight regain cannot be avoided, it can be minimized. After 2 years, 81% of those participating in programme A and 55% of those participating in programme B maintained at least a 5% weight loss.

The improvements in cardiovascular fitness (VO~2~ peak (ml/kg/min)) were also greater in programme A compared with programme B, at both 1 and 2 years. This suggests that the larger weight loss observed in programme A compared with programme B, is likely to be at least partially explained by a larger increase in physical activity levels compared with those following programme B. Therefore, a longer initial stay seems to be more helpful in initiating and maintaining changes in physical activity in morbidly obese patients.

Retention rates were very good at 1 year (average 90%); however, at 2 years they averaged only 65%. Although low retention rates could have distorted our results, it is important to notice that retention rates were almost identical in both programmes and that there were no significant differences in baseline BMI, weight or cardiovascular fitness between those who completed and those who withdrew from the study both at 1 and 2 years. This probably explains why our intention-to-treat analysis, using both last observation carried forward and baseline carried forward, gave similar results to the analysis of completers, in terms of weight loss at 1 and 2 years.

In a recently published study, Mæhlum and colleagues \[[@B19]\] showed that 14 weeks of an in-patient treatment programme for morbidly obese patients focusing on physical activity, nutrition and behavioural intervention led to an average 12% weight reduction and that with additional 1-week stays, 16 and 32 weeks afterwards, weight loss can be maintained at 1 year. These results are very similar to ours: weight reduction at 1 year of 11% (programme B) or 16% (programme A). More research is needed to ascertain the best design of intermittent residential programmes for morbid obesity, namely the length of the initial first stay and the frequency and duration of follow-up stays to minimise cost and maximise weight loss maintenance in the long term.

We need to acknowledge that the programmes described in this article are not a treatment offer available to all patients with morbid obesity in Norway and that only some health regions within the country offer part of this programme (1-3 sessions over a 1-year period) on a regular basis. Moreover, we need to recognise that the economic cost associated with these programmes is high (programme A: 18 weeks in-patient treatment over a 2-year period ≈ NOK 252,000 (EUR 34,000) (daily cost of ≈ NOK 2,000 (EUR 270); PROGRAM\<ME B: 12 weeks in-patient treatment over a 2-year period ≈ NOK 170,000 (EUR 23,000)) and that in many other countries these programmes may not be economically feasible. Although we have not performed a complete cost analysis, it is important to mention that the cost of bariatric surgery (Roux-en-Y gastric bypass) in our hospital is ≈ NOK 100,000 (EUR 13,500), excluding pre- and post-operative evaluations and follow-ups. Overall, and despite the costs, this study reassures health professionals that clinical significant weight loss can be achieved and maintained over a 2-year period with conservative treatment.

In conclusion, intermittent residential programmes for morbid obesity, with a longer initial stay, seems to be better in inducing and maintaining a larger weight loss and improvements in cardiovascular fitness at both 1 and 2 years. However, family and work pressure need to be taken into account and for some in-patient long stays may not be feasible. A longer follow-up is also needed to clearly establish the sustainability of these programmes.
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![Participant flow diagram.](ofa-0006-0288-g01){#F1}

![Changes in body weight in two intermittent residential programmes over a 2-year period. Filled columns represent visits at RRC (V1 - visit 1, V2 - visit 2, V3 - visit 3, V4 - visit 4, V5 - visit 5) and home stays (H1 - first home stay, H2 - second home stay, H3 - third home stay, H4 - fourth home stay) and dotted columns cumulative weight loss at 1 and 2 years in programme A (lighter colour) and B (darker colour). Asterisks denote significant differences between programs (\*p \< 0.01, \*\*p \< 0.0001) at different time points. Columns with symbols show significant changes in body weight overtime within group: §p \< 0.0001, \#p \< 0.05. Values are means ± SD.](ofa-0006-0288-g02){#F2}

![Changes in VO~2~ peak (ml/kg/min) in two intermittent residential programmes over a 2-year period. Lighter columns represent programme A and darker columns programme B. V1-V5 represent visits atRRC. Values are means ± SD. ANOVA revealed a significant effect of time (p \< 0.0001) and a time × group interaction (p \< 0.0001), but no main effect of group.](ofa-0006-0288-g03){#F3}

###### 

Baseline characteristics of the participants[^a^](#T1F1){ref-type="table-fn"}

                        Programme A                                    Programme B
  --------------------- ---------------------------------------------- ----------------------------------------------
  Age, years            41.2 ± 10.0                                    42.2 ± 11.2
  Male/female ratio     0.56                                           0.51
  Weight, kg            134 ± 20[\*\*](#T1F3){ref-type="table-fn"}     126 ± 19[\*\*](#T1F3){ref-type="table-fn"}
  BMI, kg/m^2^          44.9 ± 5.6[\*](#T1F2){ref-type="table-fn"}     43.3 ± 5.4[\*](#T1F2){ref-type="table-fn"}
  VO2 peak, ml/min      3,211 ± 716                                    3,319 ± 832
  VO2 peak, ml/kg/min   24.2 ± 4.4[\*\*](#T1F3){ref-type="table-fn"}   26.3 ± 5.5[\*\*](#T1F3){ref-type="table-fn"}

Values are mean ± SD. Averages with the same symbol denote statistically significant differences between programme A and programme B:

p = 0.05

p \< 0.01.

###### 

1- and 2-year weight loss after two intermittent residential programmes[^a^](#T2F1){ref-type="table-fn"}

                                     Programme A   Programme B
  ---------------------------------- ------------- ----------------------------------------------
  Analyse of completers                            
   1-year weight loss, kg            20.7 ± 10.8   13.5 ± 8.1[\*](#T2F2){ref-type="table-fn"}
   1-year weight loss, %             15.7 ± 8.1    10.7 ± 6.4[\*](#T2F2){ref-type="table-fn"}
   2-year weight loss, kg            16.0 ± 12.7   7.9 ± 11.2[\*\*](#T2F3){ref-type="table-fn"}
   2-year weight loss, %             12.5 ± 9.7    6.1 ± 8.9[\*\*](#T2F3){ref-type="table-fn"}
  Last observation carried forward                 
   1-year weight loss, kg            20.1 ± 10.9   12.9 ± 8.1[\*\*](#T2F3){ref-type="table-fn"}
   2-year weight loss, kg            15.1 ± 12.5   8.2 ± 10.1[\*\*](#T2F3){ref-type="table-fn"}
  Baseline carried forward                         
   1-year weight loss, kg            18.7 ± 12.0   12.3 ± 8.6[\*\*](#T2F3){ref-type="table-fn"}
   2-year weight loss, kg            10.5 ± 12.7   5.2 ± 9.9[\*](#T2F2){ref-type="table-fn"}

Values are mean ± SD. Symbols denote statistically significant differences between programme A and programme B:

p \< 0.01

p \< 0.0001

###### 

Percentage of participants who lost 5 or 10% of their initial body weight at 2 years within each treatment group[^a^](#T3F1){ref-type="table-fn"}

  Percentage of weight loss   Programme A   Programme B
  --------------------------- ------------- ---------------------------------------
  5%                          81%           55%[\*](#T3F2){ref-type="table-fn"}
  10%                         63%           25%[\*\*](#T3F3){ref-type="table-fn"}

Values are means. Symbols denote statistically significant differences between programme A and programme B:

p \< 0,01

p \< 0.0001.
